Discover 604 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lincoln offers a wide variety of trials focused on numerous chronic conditions like diabetes, mental health disorders, and cardiovascular diseases. Participants, including healthy volunteers seeking paid research opportunities or those with a particular health condition, can explore new treatment options while contributing to the development of groundbreaking therapies.
Filter
2
Filter results
Results: 604
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
for
Metastatic Castration-Resistant Prostate Cancer
Location: Omaha NE, Rochester MN, St Louis MO, Los Angeles CA,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06531499
Phase1, Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Omaha NE, Grand Island NE, Niles IL, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase2, Phase3, Recruiting
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Location: Omaha NE, St Louis MO, Aurora CO, Chicago IL, Dallas TX,
Sponsor: Pathos AI, Inc.
Sex: Male
Age: 18+
Code: NCT06785636
Phase1, Phase2, Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Omaha NE, Indianapolis IN, Santa Fe NM, Toledo OH,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Sex: All
Age: 18+
Code: NCT04920617
Phase2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Omaha NE, Maple Grove MN, St Louis MO, Denver CO,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Omaha NE, Grand Island NE, Waukee IA, Rochester MN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
for
Recurrent Melanoma (Skin), Metastatic Melanoma,
Location: Omaha NE, Iowa City IA, Rochester MN, St Louis MO,
Location: Omaha NE, Westwood KS, Rochester MN, Oklahoma City OK,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase1, Phase2, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Omaha NE, Waukee IA, Kansas City MO, Maywood IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
for
Large Cell Neuroendocrine Carcinoma,
Location: Omaha NE, Cleveland OH, Atlanta GA, Glen Burnie MD,
Sponsor: Molecular Partners AG
Sex: All
Age: 18+
Code: NCT07278479
Phase1, Phase2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Omaha NE, Waukee IA, Wichita KS, Iowa City IA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
for
Gastrointestinal Stromal Neoplasms
Location: Omaha NE, Knoxville TN, Canton OH, Bethesda MD, Toronto,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07585266
Phase3, Recruiting
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
for
Metastatic Colorectal Cancer
Location: Omaha NE, Madison WI, Houston TX
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07416552
Phase1, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Omaha NE, Tyler TX, Louisville KY, Detroit MI,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
for
Renal Cell Carcinoma
Location: Omaha NE, Saint Louis Park MN, Knoxville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227402
Phase3, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Omaha NE, Waukee IA, Iowa City IA, Rochester MN,